论文信息 - Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity - 字舞流文

Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity

B. Mellado | L. Dang | J. Albanell | P. Gascón | A. Rovira | M. Rolfe | C. Montagut | J. Domingo-Doménech | M. Bosch | C. Oliva | X. Filella | J. Codony-Servat | J. Ross | C. Campás | M. Tápia | J. Ross | J. Domingo-Domenech